4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-005669
Chief Financial Officer acquired 39,270 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2022-01-27 | Grant or award | +39,270 | 54,259 | D | ||
| Derivatives | |||||||
| Catinazzo Thomas Chief Financial Officer | 2022-01-27 | Grant or award · Stock Option (Right to Buy) | +78,540 | 78,540 | D | ||
Loading xslF345X03/doc4.xml…